A Mycoplasma fermentans-derived high-molecular-weight material (MDHM) is described which causes differentiation of concanavalin A-stimulated CBA/J or C57BL/6 mouse thymocytes to cytolytic effector T cells (CTLs). The effect of MDHM was inhibited by addition of monoclonal anti-interleukin-6 (IL-6) antibody. It could also be abolished after removal of adherent cells. However, adherent cell-depleted thymocytes could still form CTLs after addition of IL-6. The action of MDHM could thus be explained by the capacity of MDHM to stimulate IL-6 release from adherent cells. MDHM was active on macrophages from CBA/J and C3H/HeJ endotoxin nonresponder mice and was also capable of stimulating IL-6 release from human monocytes. On gel chromatography, MDHM had an apparent molecular size of 1.5 x 106 daltons. Treatment with RNase and DNase had no effect on either size or biological activity. Proteinase K did not abolish activity but reduced the apparent molecular size of MDHM. MDHM production by M. fermentans required either coculture with eucaryotic cell lines in RPMI 1640 medium with fetal calf serum or addition of eucaryotic cell sonic extracts to this medium. The biological activity of MDHM is not identical to that of a mitogen for murine spleen cells derived from M. arthritidis; MDHM caused only slight proliferation in this system compared with the mitogen from M. arthritidis, and the latter did not elicit IL-6 release from macrophages. The results are discussed in relation to mycoplasmas as putative etiological agents for rheumatoid arthritis, since high IL-6 titers were reported for synovial fluid from patients with this disease.
Several mycoplasma-derived factors have been reported in the past that act on immune cells in various ways. A factor in conditioned media from Mycoplasma hyorhinis-infected cell lines was shown to suppress cytotoxic responses of T cells (24) . A small basic protein, originating from M. arthritidis, was described by Atkin et al. as a potent T-cell mitogen (1) . Material with similar activity was isolated from the same organism by Kirchner and co-workers, who described its T-cell mitogenicity (15) and potential to induce interferon-T in leukocyte cultures (14) . The activity of this factor was found to be genetically restricted to certain mouse strains (7, 11) . Mitogenicity is not confined to products from M. arthritidis (4) .
We describe here an M. fermentans-derived high-molecular-weight material (MDHM) that is not mitogenic for murine spleen cells but stimulates release of high titers of IL-6 from murine peritoneal macrophages and human monocytes. We found that MDHM indirectly, through IL-6, also activates thymocytes to become cytolytic. Since mycoplasmas have been implicated as an etiological agent of rheumatoid arthritis, these findings may be of clinical significance. They may explain some of the phenomena observed in chronically inflamed arthritic joints, such as excessive production of IL-6 in the synovial fluid of arthritis patients (12, 13, 29) , resulting in T-and B-cell activation. Identification of M. fermentans. The M. fermentans strain used in this study (D15-86) was isolated from a contaminated HL 60 line. It was propagated in modified Friis medium (10) consisting of Hanks balanced salt solution (10x; 50 ml), deionized water (1,230 ml), Bacto brain heart infusion (Difco Laboratories, Detroit, Mich.; 8.2 g), Bacto PPLO broth (Difco; 8.7 g), swine serum (heated at 56°C for 30 min; 150 ml), fresh yeast extract (50% [wt/vol]; 30 ml), phenol red (1% [wt/vol]; 1.25 ml), and penicillin (2,000 IU ml-'). M.fermentans D15-86 was identified by an indirect immunofluorescence test (9) .
Preparation of MDHM. MDHM was enriched from growth medium of M. fermentans-infected HL 60 cells as follows. Infected HL 60 cells were cultured for 4 days and then removed by low-speed centrifugation (200 x g for 7 min).
Mycoplasmas and cell debris were spun down at 21,000 x g for 1 h, and MDHM was precipitated from the supernatant by 90% saturation with (NH4)2SO4. The precipitate was dissolved in a minimum of Dulbecco phosphate-buffered saline (D-PBS) and dialyzed exhaustively against this buffer. Occasional turbidity was removed by 1 h of centrifugation at 21,000 x g. The MDHM preparation was routinely tested for the absence of mycoplasmas by adding samples to mycoplasma-free HL 60 cultures and staining the cells for mycoplasmas after 4 to 5 days with 2,6-diamidino-2-phenyl-indol (Boehringer GmbH, Mannheim, Federal Republic of Germany) (20) .
MDHM detection by induction of cytolytic effector T cells (CTLs) in thymocyte cultures. Single-cell suspensions of thymocytes were prepared in Hanks balanced salt solution containing 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid buffer, pH 7.4 (BSS), by gentle teasing of thymus tissue from C57BL/6 or CBA/J mice 5 to 7 weeks of age. Debris was removed by filtration through a nylon sieve. In some experiments, CBA/J thymocytes were depleted of adherent cells. To this end, 1 x 108 to 2 x 108 thymocytes were applied to a 20-ml Sephadex G10 column (Pharmacia, Uppsala, Sweden) equilibrated with BSS-5% FCS. Nonadherent cells were eluted with the same buffer and collected. Thymocytes were adjusted with RPMI 1640-5% FCS-2 mM glutamine-2.5 x 10-5 M 2-mercaptoethanol to 4 x 10' cells per ml (CBA/J cells) or 6 x 106 cells per ml (C57BL/6 cells), and ConA was added to a concentration of 8 ,ug/ml. Volumes (100 ,lp) of cell suspension were added to 100 ,u of serial sample dilutions (MDHM or other mediators) in roundbottom microtiter plates (Greiner, Nurtingen, Federal Republic of Germany). Alternatively, 500 RI of cell suspension and 500 ,ul of sample were combined in 13-ml round-bottom tubes (Falcon tubes; Becton-Dickinson, Heidelberg, Federal Republic of Germany) when effector-to-target-cell titrations were intended. Lectin-mediated lysis was determined after a 3-day cultivation period as described previously (18) .
Briefly, 100 ,ul of supernatant was removed from each well and replaced by 100 ,ul of medium with 104 phytohemagglutinin-coated 51Cr-labeled P815 cells. Alternatively, viable cells were counted in the Falcon tube cultures and adjusted to 106 cells per ml in RPMI 1640-10% FCS. One-hundredmicroliter serial dilutions of these effector cells were mixed in round-bottom microtiter plates with 104 51Cr-labeled target cells. 51Cr release was determined after 4 h, and percent specific release was calculated from the appropriate controls. fermentans. After a 6-day cultivation period, the medium was freed of mycoplasmas by centrifugation for 45 min at 21,000 x g, and possibly remaining mycoplasmas were inactivated by heat treatment (1 h, 57°C). Heat-stable MDHM activity was determined by the IL-6 induction assay.
Molecular characterization of MDHM. (i) Ultracentrifugation. MDHM was centrifuged for 1 h at 105,000 x g. MDHM activity was tested in the supematant, the suspended pellet, and the untreated control preparation.
(ii) Nuclease treatment. To an MDHM preparation in RPMI 1640, RNase and DNase I (both from Boehringer) were added at final concentrations of 80 pug/ml (RNase; 40 Kunitz U/mg) and 100 ,ug/ml (DNase; 2,000 U/mg). After a 4-h incubation at 37°C, a 1.35-ml sample was subjected to gel filtration on a Sephacryl S 300 column (1.6 by 34.5 cm) (Pharmacia, Freiburg, Federal Republic of Germany). The elution buffer was D-PBS, and the flow rate was 10 mil/h. MDHM activity in the eluate was tested by the CTL induction assay.
(iii) Protease treatment. MDHM was separated from bulk protein by gel filtration on a Sephacryl S 300 column as described above. Fractions containing the main MDHM activity were pooled from several runs' and concentrated by ultrafiltration (Amicon PM 10; Amicon Corp., Lexington, Mass.). To 2.2 ml of such a MDHM preparation containing 2.29 mg of protein, 0.46 mg of proteinase K (27 milli-Anson U/mg; Merck-Schuchardt, Darmstadt, Federal Republic of Germany) was added. The reaction was stopped after a 1-h incubation at 37°C by addition of 5% (vol/vol) FCS, and the sample was immediately applied to a Sephacryl S 300 column as described above. MDHM activity in the eluate was tested by the CTL induction assay.
Spleen cell proliferation assay. Splenocytes from CBA/J mice (10 to 12 weeks of age) were prepared as described for thymocytes. The cell concentration was adjusted to 6 x 106 cells per ml in RPMI 1640-5% FCS-2 mM glutamine. One hundred microliters of cell suspension was added to 100-pd serial dilutions of potential mitogens in round-bottom microtiter plates. Cells were cultured for 3 days. For the last 7 h, 1 ,uCi of [methyl-3H]thymidine per well (specific activity, 0.25 mCi/pRmol; Amersham-Buchler, Braunschweig, Federal Republic of Germany) was added in 20-pdl volumes to the cultures. Acid-insoluble material was precipitated on glass fiber filters with a multiple automatic sample harvester, and radioactivity was determined in a liquid scintillation counter.
RESULTS
Discovery of MDHM as a helper factor for thymocyte differentiation. MDHM was first discovered as an activity in the culture medium of M. fermentans-infected HL 60 cells that allowed the differentiation of murine thymocytes to CTLs. MDHM-dependent CTL development, measured by a lectin-dependent 51Cr release assay, showed a distinct dose response (Fig. 1) . MDHM did not act on thymocytes which had been depleted of adherent cells by a passage over Sephadex G 10 ( Fig. 2) , suggesting that its effect might be indirect, possibly involving factors released from the adherent-cell population. Two findings speak in favor of IL-6 as a mediator in this system. (i) CTL response could be reconstituted by addition of murine or human recombinant IL-6 to adherent cell-depleted thymocytes (Fig. 2) , and cytolytic activity increased with the IL-6 activity over a wide range (Fig. 3). (ii) In addition, MDHM-mediated CTL differentiation was inhibited by a monoclonal anti-IL-6 antibody (Table  1) . This inhibition could be overcome by IL-2, which indicates that the antibody preparation (ascitic fluid) was not unspecifically toxic at the dilution used (Table 1) .
MDHM induces IL-6 release. In order to clarify whether the role of MDHM was to provide IL-6 from adherent cells as one obligatory step in CTL development (19, 23, 25) , we next tested the capacity of MDHM to cause IL-6 release from murine peritoneal macrophages and human peripheral blood monocytes. MDHM was able to rapidly stimulate IL-6 production ( Table 2 ). IL-6 release from MDHM-stimulated human monocytes was equally fast and led to comparable IL-6 release (1,280 U/ml after 24 h [medium control, 256 U/ml]). A parallel, LPS-stimulated culture produced 1,280 U of IL-6 per ml. MDHM-mediated IL-6 release was concentration dependent (Fig. 4) . This direct effect of MDHM on the release of IL-6 from macrophages was a more sensitive assay for MDHM than the cytotoxicity test which, however, has the advantage that it covers a wider concentration range of MDHM (compare Fig. 4 with Fig. 1 ). Accordingly, depending on the requirement, either MDHM-dependent differentiation of thymocytes to CTLs or MDHM-mediated IL-6 production by peritoneal macrophages was used to measure this activity.
MDHM tected MDHM activity in the culture medium of the mycoplasma-infected human cell line HL 60, it was unclear whether this material was a product of the mycoplasmas themselves or of these particular eucaryotic host cells, Table 4 (experiment 1) illustrate that M. fermentans, when cultured in this cell homogenate, produced MDHM capable of inducing high IL-6 titers.
Molecular characterization of MDHM. When a preparation of MDHM was centrifuged for 1 h at 105,000 x g, most MDHM activity remained in the supernatant, although some activity was found in the microsomal pellet. Gel filtration on a Sephacryl S 300 column identified MDHM as a highmolecular-weight material, eluting very close to the void volume of this molecular sieve, which has a fractionation range of 104 to 1.5 x 106 daltons (Fig. 5) . Incubation of a IL-6 activity was determined by the hybridoma growth test as described for Table 2 .
b Cultures were done in 25-cm2 tissue culture flasks. HL 60 lysate-enriched medium was RPMI 1640 medium substituted with sonic extracts from HL 60 cells. Stimulating materials were freed of mycoplasmas by high-speed centrifugation and added at zero time. IL-6 activity was determined after 48 h.
c Cultures were done in 0.6-ml volumes in multiwell tissue culture plates. Stimulants were added at zero time. IL-6 activity was determined after 24 h. (Fig. 6) . The influence of the two materials on the development of thymocytes to CTLs is shown in Fig. 7 . In contrast to MDHM, even highly purified MAS had only marginal activity in this assay. Moreover, MAS, when used at concentrations which caused maximal proliferation in the spleen assay, did not induce IL-6 production in macrophage cultures (Table 4 , experiment 2). These experiments strongly suggest that MDHM and MAS are different biological materials.
Macrophages from C3H/HeJ LPS nonresponder mice respond to MDHM. The capacity of MDHM to stimulate IL-6 release in macrophage cultures was reminiscent of LPS effects (26) . It was therefore important to study the influence of MDHM on macrophages from genetically LPS nonresponder mice (21, 22) to exclude a contamination of our preparations with LPS. MDHM led to IL-6 release in CBA/J and C3H/HeJ macrophage cultures, whereas LPS acted only on CBA/J macrophages (Table 4 , experiments 3 and 4). 
DISCUSSION
Studies in our laboratory which were originally undertaken in order to search for cytokines which caused differentiation of CTLs from thymocytes led to the discovery of a biological activity that had the desired effect but which was only generated in the presence of live M. fermentans. According to the data presented here, this material, which we have tentatively named MDHM, acts via liberation of IL-6 by accessory cells and is not identical to MAS from M. arthritidis, nor is its activity due to bacterial endotoxin. These points, as well as possible implications of our findings for inflammatory processes such as occur in rheumatoid arthritis, will be discussed in detail below.
Active (12, 13, 29) , and the suggestion was made that the infiltration of the synovium by lymphocytes and plasma cells in affected joints may be due to IL-6 (12) . Furthermore, IL-6 has pleiotropic effects on B and T lymphocytes (32) as well as on phagocytes (3) . In particular, it serves as a helper factor in the in vitro induction of human and murine cytolytic T cells (19, 23) . It is interesting to recall that along with other mycoplasmas, M. fermentans has been discussed as a possible cause for rheumatoid arthritis in humans (16, 31) , although isolation and characterization of these microorganisms from the joints of patients has proved difficult, and the results have been conflicting (2, 5) .
